Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma

Work

Year: 2007

Type: article

Abstract: We conducted a phase 3, randomized, double-blind, placebo-controlled trial of sorafenib, a multikinase inhibitor of tumor-cell proliferation and angiogenesis, in patients with advanced clear-cell rena... more

Source: New England Journal of Medicine

Authors: Bernard Escudier, Tim Eisen, Walter M. Stadler, Cezary Szczylik, Stéphane Oudard +14 more

Institutions: Institut Gustave Roussy, Cancer Research UK Cambridge Center, University of Chicago, Hôpital Européen, Hôpital Européen Georges-Pompidou +8 more

Language: English

Cites: 26

Cited by: 4,709

Related to: 10

FWCI: 382.5

Citation percentile (by year/subfield): 100

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

Sustainable Development Goal: Good health and well-being

Open Access status: bronze